Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll Deficiency

NCT00056589 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Bleeding Disorder
Congenital FXIII Deficiency

Interventions

DRUG: catridecacog

Sponsor

Novo Nordisk A/S